Literature DB >> 35092046

Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure.

Bénédicte Caron1, Mathurin Fumery2, Patrick Netter3, Laurent Peyrin-Biroulet1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35092046     DOI: 10.1111/apt.16770

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

Review 1.  Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.

Authors:  Rieke Alten; Yoorim An; Dong-Hyeon Kim; SangWook Yoon; Laurent Peyrin-Biroulet
Journal:  Clin Drug Investig       Date:  2022-06-03       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.